e.l.f. Cosmetics
ELF
$84.01
+8.60%
e.l.f. Beauty, Inc. is a multi-brand beauty company offering inclusive, accessible, clean, vegan, and cruelty-free cosmetics and skincare products through its e-commerce channels and retail stores. As a disruptive player in the household & personal products industry, e.l.f. has carved out a distinct identity by combining high-quality, affordable products with a strong digital-first marketing strategy that resonates with younger consumers. The current investor narrative centers on the company's ability to sustain its impressive revenue growth trajectory amid a volatile macroeconomic environment, with recent attention focused on its Q4 FY2026 earnings beat, the launch of a new hair care line, and tariff refunds that boosted sentiment. However, debates persist around margin compression, elevated inventory levels, and the sustainability of its growth premium in a competitive beauty landscape.…
ELF
e.l.f. Cosmetics
$84.01
Related headlines
Investment Opinion: Should I buy ELF Today?
Rating: Hold. The core thesis is that e.l.f. Beauty's strong revenue growth and healthy gross margins are offset by margin compression and a high trailing valuation, making the risk/reward balanced at current levels. The consensus is Buy with an average target of $76.69, essentially in line with the current price of $77.36. Supporting evidence includes: 1) Revenue growth of 35.1% YoY, far above the industry average of 3-5%; 2) Gross margin of 72.7%, indicating pricing power; 3) Positive free cash flow of $190.1M TTM; 4) Forward P/E of 21.1x, which is reasonable if earnings recover as expected. However, the trailing P/E of 134.7x and the Q4 net loss highlight the risk. The biggest risks are: 1) Further margin compression from rising SG&A; 2) Deceleration in revenue growth; 3) Multiple contraction if earnings disappoint. This Hold would upgrade to Buy if the forward P/E compresses below 15x or if operating margins sustainably exceed 10%. It would downgrade to Sell if revenue growth falls below 20% or if the company reports another quarterly loss. Overall, e.l.f. appears fairly valued relative to its growth prospects, but the high trailing multiple warrants caution.
Sign up to view all
ELF 12-Month Price Forecast
e.l.f. Beauty is at a crossroads. The company's revenue growth remains impressive, but the deceleration and margin compression introduce uncertainty. The forward P/E of 21.1x is reasonable if earnings recover, but the trailing P/E of 134.7x highlights the risk. The neutral stance reflects the balanced risk/reward: the stock could rally if margins improve, but could also fall if growth disappoints. Key developments to watch are the next earnings report (margin trends) and the success of the hair care line. An upgrade to bullish would require sustained operating margins above 10% and revenue growth above 30%; a downgrade to bearish would follow a quarterly loss or growth below 20%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on e.l.f. Cosmetics's 12-month outlook, with a consensus price target around $76.69 and implied upside of -8.7% versus the current price.
Average Target
$76.69
0 analysts
Implied Upside
-8.7%
vs. current price
Analyst Count
—
covering this stock
Price Range
$50 - $97
Analyst target range
e.l.f. Beauty is covered by 16 analysts, with a consensus recommendation of 'Buy' (mean recommendation of 1.83 on a 1-5 scale, where 1 is Strong Buy). The average target price is $76.69, which is slightly below the current price of $77.36, implying a marginal downside of -0.9%. The distribution shows a bullish tilt, with recent ratings from B. Riley, BofA, Jefferies, and Canaccord Genuity all at 'Buy', while Piper Sandler and UBS are 'Neutral', and Morgan Stanley is 'Equal Weight'. The consensus leans bullish but with caution, as the average target is essentially in line with the current price. The target range spans from a low of $50.00 to a high of $97.00. The high target of $97.00 implies 25.4% upside and likely assumes successful execution of the new hair care line, margin recovery, and sustained revenue growth. The low target of $50.00 implies a 35.4% downside and reflects risks of further margin compression, competitive pressure, or a broader consumer spending slowdown. The wide spread ($47) indicates high uncertainty among analysts about the company's future performance. Recent rating actions have been stable, with no downgrades in the last three months, suggesting analysts are maintaining their positions despite the stock's volatility. The lack of a clear upside to the average target suggests that the stock is fairly valued near current levels based on consensus expectations.
Bulls vs Bears: ELF Investment Factors
e.l.f. Beauty presents a classic growth-at-a-reasonable-price debate. On the bull side, the company boasts exceptional revenue growth (35.1% YoY), a healthy gross margin (72.7%), positive free cash flow ($190.1M TTM), and a consensus Buy rating with a high target implying 25.4% upside. On the bear side, the Q4 net loss of -$49.4M, decelerating growth, and a trailing P/E of 134.7x (vs. industry 25x) highlight significant risks. The single most important tension is whether the company can restore profitability and sustain growth to justify its premium valuation. Currently, the bear case has stronger evidence due to the earnings miss and high multiple, but the bull case could prevail if margins recover and growth reaccelerates.
Bullish
- Strong Revenue Growth: Revenue grew 35.1% YoY to $449.3M in Q4 FY2026, significantly outpacing the industry average of 3-5%. This demonstrates continued market share gains and strong consumer demand for e.l.f.'s affordable, clean beauty products.
- Healthy Gross Margin: Gross margin remained robust at 72.7% in Q4 FY2026, well above the industry average. This indicates strong pricing power and efficient cost management, providing a buffer against input cost inflation.
- Positive Free Cash Flow: Trailing twelve-month free cash flow was $190.1M, representing a free cash flow yield of approximately 5.4%. This cash generation supports reinvestment in growth initiatives and provides financial flexibility.
- Bullish Analyst Consensus: The consensus recommendation is 'Buy' with a mean score of 1.83 (1=Strong Buy). The high analyst target of $97 implies 25.4% upside from the current price of $77.36, reflecting confidence in the company's growth trajectory.
Bearish
- Negative Net Income in Q4: e.l.f. reported a net loss of -$49.4M in Q4 FY2026, swinging from net income of $39.4M in Q3. This was driven by elevated SG&A expenses of $319.1M, which compressed operating margin to just 1.6% from 13.8% in Q3.
- Extremely High Trailing P/E: The trailing P/E of 134.7x is far above the industry average of 25x, leaving no room for error. Any earnings miss could trigger a severe multiple contraction and significant downside.
- Decelerating Revenue Growth: Revenue growth decelerated from 49.5% YoY in Q3 to 35.1% in Q4. While still strong, the sequential slowdown raises questions about the sustainability of the growth rate as the company matures.
- High Beta and Volatility: With a beta of 2.389, the stock is nearly 2.4 times more volatile than the S&P 500. This amplifies downside risk in a market downturn, as evidenced by the 35.1% decline over the past year.
ELF Technical Analysis
e.l.f. Beauty is in a pronounced downtrend over the past year, with the stock down 35.1% over the trailing twelve months. The current price of $77.36 sits at 27.7% of its 52-week range (low $48.82, high $150.99), indicating the stock is trading near the lower end of its yearly range. This positioning suggests the market has priced in significant headwinds, but the stock is not yet at its nadir, leaving potential for further downside if fundamentals deteriorate. The 52-week low of $48.82 represents a key support level, while the high of $150.99 is a distant resistance. With a beta of 2.389, the stock is nearly 2.4 times more volatile than the S&P 500, amplifying both upside and downside risks. Short-term momentum has been strongly positive, with the stock gaining 19.9% over the past month and 16.7% over the past three months. This recent rally diverges sharply from the 1-year decline, suggesting a potential trend reversal or a bear market rally. The 1-month relative strength versus the S&P 500 is +19.1%, indicating the stock is outperforming the broader market in the near term. However, the 3-month relative strength of +13.2% shows the outperformance is recent, and the stock remains well below its 52-week high, so caution is warranted. The 52-week high of $150.99 acts as a major resistance level, while the 52-week low of $48.82 provides support. A breakout above $150.99 would signal a resumption of the prior uptrend, while a breakdown below $48.82 could trigger further selling. The stock's high beta of 2.389 means it is significantly more volatile than the market, which is important for risk management. The recent rally from the June low of $49.57 to $77.36 represents a 56% gain, but the stock remains 49% below its 52-week high, indicating that the downtrend is still intact until a higher high is established.
Beta
2.39
2.39x market volatility
Max Drawdown
-66.2%
Largest decline past year
52-Week Range
$49-$151
Price range past year
Annual Return
-30.5%
Cumulative gain past year
| Period | ELF Return | S&P 500 |
|---|---|---|
| 1m | +24.6% | +1.4% |
| 3m | +33.3% | +3.9% |
| 6m | -1.1% | +6.3% |
| 1y | -30.5% | +16.0% |
| ytd | +8.0% | +8.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ELF Fundamental Analysis
Revenue growth remains robust, with the most recent quarterly revenue of $449.3 million representing a 35.1% year-over-year increase. However, the growth trajectory has decelerated from the 49.5% growth seen in the prior quarter (Q3 FY2026 revenue of $489.5 million) and the 47.5% growth in Q2 FY2026. The sequential decline from Q3 to Q4 suggests a potential slowdown, though the company's fiscal year-end seasonality may play a role. The revenue segments data shows only a single reportable segment, indicating the entire business is driving growth. The strong top-line expansion supports the investment case for a high-growth beauty brand, but the deceleration warrants monitoring. Profitability has been mixed. The company reported a net loss of -$49.4 million in Q4 FY2026, compared to net income of $39.4 million in Q3, swinging to a loss due to higher operating expenses and interest costs. Gross margin remains healthy at 72.7%, but operating margin compressed to 1.6% in Q4 from 13.8% in Q3, reflecting elevated SG&A spending (SG&A of $319.1 million vs. $279.9 million in Q3). The net margin turned negative at -11.0% in Q4, a sharp reversal from the 8.0% net margin in Q3. For the trailing twelve months, free cash flow was $190.1 million, indicating the business generates cash despite quarterly volatility. The balance sheet appears manageable: debt-to-equity is 0.81, and the current ratio is 2.35, suggesting adequate liquidity. However, the company's ROE is low at 2.3%, and the negative net income in Q4 raises concerns about earnings quality. The free cash flow yield (FCF/ market cap) is approximately 5.4%, which is reasonable for a growth company.
Quarterly Revenue
$449292000.0B
2026-03
Revenue YoY Growth
+35.1%
YoY Comparison
Gross Margin
72.7%
Latest Quarter
Free Cash Flow
$190062000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ELF Overvalued?
Since net income is positive on a trailing twelve-month basis (TTM net income of $26.3 million, calculated from the last four quarters), the primary valuation metric is the P/E ratio. The trailing P/E is 134.7x, while the forward P/E is 21.1x. The large gap between trailing and forward P/E implies the market expects a sharp earnings recovery in the coming year, driven by margin expansion and continued revenue growth. This forward multiple is more reasonable for a growth stock but still reflects optimistic expectations. Compared to the industry average (household & personal products), e.l.f. trades at a significant premium. The PS ratio of 2.16 is below the industry average of 3.5x (estimated), suggesting a discount on a sales basis, but the trailing P/E of 134.7x is far above the industry average of 25x. This discrepancy highlights that e.l.f. is valued more on its growth potential than current earnings. The premium may be justified by its superior revenue growth (35% YoY) versus the industry average of 3-5%, but the high multiple leaves little room for error. Historically, e.l.f.'s trailing P/E has ranged from 27x to 645x over the past two years. The current trailing P/E of 134.7x is near the middle of that range but well above the lows seen in mid-2024. The forward P/E of 21.1x is near the lower end of its historical forward range (which has been as high as 60x), suggesting that the market is pricing in a normalization of earnings. This could indicate a value opportunity if the company delivers on its earnings guidance, but it also reflects the risk of a permanent earnings decline.
PE
134.7x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 27x~101x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
25.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The primary financial risk is margin compression. Operating margin collapsed from 13.8% in Q3 to 1.6% in Q4 due to a 14% sequential increase in SG&A expenses to $319.1M. This led to a net loss of -$49.4M, a stark reversal from the $39.4M profit in Q3. The company's debt-to-equity of 0.81 is manageable, but the negative net income raises concerns about earnings quality. Additionally, the trailing P/E of 134.7x implies extreme expectations for future earnings growth, leaving the stock vulnerable to any disappointment. Market & Competitive Risks: The stock's beta of 2.389 makes it highly sensitive to macro volatility, and the 35.1% decline over the past year already reflects this. The beauty industry is intensely competitive, with established players like L'Oréal and Estée Lauder, as well as indie brands. e.l.f.'s premium valuation (trailing P/E 134.7x vs. industry 25x) could compress if growth decelerates further. Recent news about tariff refunds and a new hair care line provided a boost, but these are one-time or unproven catalysts. Worst-Case Scenario: If revenue growth continues to decelerate and margins fail to recover, the stock could fall to its 52-week low of $48.82, representing a 36.9% decline from the current price of $77.36. This scenario could be triggered by a broader consumer spending slowdown, increased competition, or a failure of the hair care line to gain traction. The analyst low target of $50 aligns with this downside, suggesting a realistic worst-case loss of approximately 35%.
FAQ
The key risks are: 1) Margin compression: Operating margin fell to 1.6% in Q4 from 13.8% in Q3, and a net loss of -$49.4M was reported. If margins don't recover, earnings will disappoint. 2) High valuation: The trailing P/E of 134.7x leaves no room for error; any earnings miss could trigger a severe sell-off. 3) Growth deceleration: Revenue growth slowed from 49.5% to 35.1% YoY, and further deceleration could lead to multiple compression. 4) Macro sensitivity: With a beta of 2.389, the stock is highly volatile and vulnerable to market downturns. The most severe risk is a combination of these factors, which could push the stock to its 52-week low of $48.82, a 36.9% decline from current levels.
The 12-month outlook for ELF is mixed. In the bull case (25% probability), the stock could reach $85-$97, driven by successful execution of the hair care line and margin recovery. The base case (50% probability) sees the stock trading in a $65-$80 range as growth moderates and margins stabilize. The bear case (25% probability) could see the stock fall to $48-$60 if growth decelerates further or margins remain compressed. The most likely scenario is the base case, which assumes revenue growth of 25-30% and operating margins of 8-10%. The average analyst target of $76.69 aligns with this view, implying the stock is fairly valued near current levels.
e.l.f. Beauty's valuation is a tale of two metrics. The trailing P/E of 134.7x is extremely high compared to the industry average of 25x, suggesting the stock is overvalued based on current earnings. However, the forward P/E of 21.1x is more reasonable and implies the market expects a sharp earnings recovery. The PS ratio of 2.16 is below the industry average of 3.5x, indicating a discount on a sales basis. Historically, the trailing P/E has ranged from 27x to 645x over the past two years, so the current level is near the middle. Overall, the stock appears fairly valued on a forward basis but overvalued on a trailing basis, reflecting the market's optimism about future profitability.
e.l.f. Beauty is a high-growth company with strong revenue growth (35.1% YoY) and a healthy gross margin (72.7%), but it carries significant risks. The trailing P/E of 134.7x is extremely high, and the company reported a net loss of -$49.4M in Q4 FY2026. The consensus analyst target of $76.69 is essentially in line with the current price of $77.36, implying limited upside. For long-term growth investors with a high risk tolerance, ELF could be a good buy if you believe margins will recover and growth will sustain. However, for value-oriented or risk-averse investors, the high valuation and earnings volatility make it a risky proposition. The stock is best suited for those who can tolerate a potential 35% downside to the 52-week low of $48.82.
e.l.f. Beauty is better suited for long-term investment, given its high growth potential and the time needed for margin recovery. The stock's beta of 2.389 makes it too volatile for short-term trading, as sharp swings can lead to losses. The company does not pay a dividend, so returns depend entirely on price appreciation. With a forward P/E of 21.1x, the stock could deliver solid returns over a 3-5 year horizon if growth and margins improve. However, short-term investors should be cautious due to the recent earnings miss and high trailing valuation. A minimum holding period of 2-3 years is recommended to allow the company's growth story to play out.